Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPPIX.L Regulatory News (PPIX)

  • There is currently no data for PPIX

ProPhotonix Share Dealing

5 Aug 2014 07:00

RNS Number : 2359O
ProPhotonix Limited
05 August 2014
 

 

5 August 2014

 

ProPhotonix Limited

("ProPhotonix" or "the Company")

 

ProPhotonix Share Dealing

 

600 Group PLC acquires 26.3% stake in ProPhotonix from existing shareholders at an implied price of 5.0 pence ($0.08) per share

 

ProPhotonix Limited (London Stock Exchange - AIM: PPIX and PPIR, OTC: STKR), a designer and manufacturer of LED illumination systems and laser diode modules with operations in Ireland and the United Kingdom, notes that 600 Group PLC (the "600 Group") has announced that it has acquired 22,042,143 shares of common stock of ProPhotonix from existing shareholders, representing 26.3% of the outstanding shares of ProPhotonix, for consideration to be satisfied by the issue of 4,925,621 ordinary shares of the 600 Group. Based on the closing price per 600 Group share of 22.375 pence on 1 August 2014, being the last business day prior to the date of the announcement by 600 Group, this acquisition represents a price of 5.0 pence ($0.08) per PPIX share, which would indicate a premium of approximately 120% to the closing price of PPIX shares (2.275 pence) on 1 August 2014. ProPhotonix, incorporated in the State of Delaware, United States of America, is not subject to the UK City Code on Takeovers and Mergers ("City Code"), as disclosed in the Company's Admission Document dated 20 December 2010.

 

Tim Losik, President and CEO, stated "The Board is pleased to see this level of interest in the Company's equity at what represents a substantial premium to market price. The Company has taken significant steps to reduce costs over the past 16 months, while increasing revenue, with considerable progress achieved towards positive EBITDA and cash flow. The Directors of ProPhotonix look forward to a positive and constructive collaboration with the 600 Group, which is expected to become the Company's largest shareholder on 8 August 2014."

 

Enquiries:

ProPhotonix Limited

Tim Losik, President and CEO

 

ir@prophotonix.com

 

Tel: +1 603 870 8220

N+1 Singer

Andrew Craig/ Ben Wright

Tel: +44 (0) 207 496 3000

Nominated Adviser and Broker

 

About ProPhotonix

ProPhotonix Limited, headquartered in Salem, New Hampshire, is an independent designer and manufacturer of diode-based laser modules and LED systems for industry leading OEMs and medical equipment companies. In addition, the Company distributes premium diodes for Oclaro, Osram, QSI, Panasonic, and Sony. The Company serves a wide range of markets including the machine vision, industrial inspection, security, and medical markets. ProPhotonix has offices and subsidiaries in the U.S., Ireland, U.K., and Europe. For more information about ProPhotonix and its innovative products, visit the Company's web site at www.prophotonix.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRLIFELTAIEIIS
Date   Source Headline
13th Aug 20127:00 amRNSHalf Yearly Report
25th May 20122:30 pmRNSGrant of Options (Replacement)
17th May 20127:00 amRNSAGM Statement
1st May 20124:21 pmRNSPosting of Annual Report and Accounts
5th Apr 20127:00 amRNSAppointment of Three New Distribution Partners
26th Mar 20127:00 amRNSGrant of Options
19th Mar 20127:00 amRNSAppointment of Joint Broker
1st Mar 20127:00 amRNSFinal Results
1st Feb 20127:00 amRNSChange of Name of Nominated Adviser and Broker
19th Jan 20127:00 amRNSTrading Update and New Product Launch
27th Oct 20117:00 amRNS3rd Quarter Results
28th Jul 20117:00 amRNSHalf Yearly Report
20th Jul 20117:00 amRNSNotice of Results
13th Jul 20117:00 amRNSIssue of Equity
26th May 20111:51 pmRNSDirector/PDMR Shareholding
24th May 20115:09 pmRNSDirector/PDMR Shareholding
10th May 20117:00 amRNSChange of Adviser
4th May 20117:00 amRNS1st Quarter Results
19th Apr 20115:28 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.